AR019975A1 - Derivados de feniletilamina, procedimiento para su preparacion, preparado farmaceutico que los contiene y su utilizacion - Google Patents
Derivados de feniletilamina, procedimiento para su preparacion, preparado farmaceutico que los contiene y su utilizacionInfo
- Publication number
- AR019975A1 AR019975A1 ARP990103802A ARP990103802A AR019975A1 AR 019975 A1 AR019975 A1 AR 019975A1 AR P990103802 A ARP990103802 A AR P990103802A AR P990103802 A ARP990103802 A AR P990103802A AR 019975 A1 AR019975 A1 AR 019975A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedure
- derivatives
- preparation
- pheniletilamine
- pharmaceutical preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Derivados de feniletilamina de formula general (I) en la cual los R, independientemente entre sí, pueden significar hidrogeno o fluor, en forma de lasbases libres o de las correspondientes sales por adicion de ácidos con ácidos farmacologicamente inocuos. Los compuestos presentan efectos antagonistas delreceptor LTB4. Procedimiento para la preparacion de los mismos, preparado farmacéutico que los contiene y su utilizacion.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19834713A DE19834713A1 (de) | 1998-07-31 | 1998-07-31 | Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
AR019975A1 true AR019975A1 (es) | 2002-03-27 |
Family
ID=7876091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990103802A Pending AR019975A1 (es) | 1998-07-31 | 1999-07-30 | Derivados de feniletilamina, procedimiento para su preparacion, preparado farmaceutico que los contiene y su utilizacion |
Country Status (13)
Country | Link |
---|---|
US (1) | US6133479A (es) |
EP (1) | EP1100767B1 (es) |
JP (1) | JP2002522411A (es) |
AR (1) | AR019975A1 (es) |
AT (1) | ATE221043T1 (es) |
AU (1) | AU5286499A (es) |
CA (1) | CA2338649C (es) |
DE (2) | DE19834713A1 (es) |
DK (1) | DK1100767T3 (es) |
ES (1) | ES2177308T3 (es) |
PE (1) | PE20000866A1 (es) |
PT (1) | PT1100767E (es) |
WO (1) | WO2000007977A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19834713A1 (de) * | 1998-07-31 | 2000-02-03 | Boehringer Ingelheim Pharma | Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE10344447A1 (de) * | 2003-09-25 | 2005-05-12 | Degussa | Verfahren zur Herstellung O-alkylierter Aminoalkohole |
BRPI0513351A (pt) * | 2004-07-14 | 2008-05-06 | Inflammation Res Ct Company Lt | métodos para inibir metástase de tumor, e inibir adesão de célula de tumor às células endotelias e/ou inibir a permeabilidade capilar na forma de migração transendotelial de células de tumor, método de triagem para um inibidor da permeabilidade capilar para células de tumor, e, uso de um antagonista de leucotrieno ou um sal do mesmo farmaceuticamente aceitável |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4424713A1 (de) * | 1994-07-13 | 1996-01-18 | Boehringer Ingelheim Kg | Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe |
DE4424714A1 (de) * | 1994-07-13 | 1996-01-18 | Boehringer Ingelheim Kg | Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff |
US5585492A (en) * | 1994-10-11 | 1996-12-17 | G. D. Searle & Co. | LTA4 Hydrolase inhibitors |
DE19718334A1 (de) * | 1997-04-30 | 1998-11-05 | Boehringer Ingelheim Pharma | Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE19834713A1 (de) * | 1998-07-31 | 2000-02-03 | Boehringer Ingelheim Pharma | Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
-
1998
- 1998-07-31 DE DE19834713A patent/DE19834713A1/de not_active Withdrawn
-
1999
- 1999-07-20 PE PE1999000725A patent/PE20000866A1/es not_active Application Discontinuation
- 1999-07-22 JP JP2000563612A patent/JP2002522411A/ja active Pending
- 1999-07-22 PT PT99938314T patent/PT1100767E/pt unknown
- 1999-07-22 DK DK99938314T patent/DK1100767T3/da active
- 1999-07-22 AU AU52864/99A patent/AU5286499A/en not_active Abandoned
- 1999-07-22 ES ES99938314T patent/ES2177308T3/es not_active Expired - Lifetime
- 1999-07-22 WO PCT/EP1999/005221 patent/WO2000007977A1/de active IP Right Grant
- 1999-07-22 EP EP99938314A patent/EP1100767B1/de not_active Expired - Lifetime
- 1999-07-22 DE DE59902136T patent/DE59902136D1/de not_active Expired - Lifetime
- 1999-07-22 AT AT99938314T patent/ATE221043T1/de active
- 1999-07-22 CA CA002338649A patent/CA2338649C/en not_active Expired - Fee Related
- 1999-07-29 US US09/363,864 patent/US6133479A/en not_active Expired - Lifetime
- 1999-07-30 AR ARP990103802A patent/AR019975A1/es active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2000007977A1 (de) | 2000-02-17 |
AU5286499A (en) | 2000-02-28 |
ATE221043T1 (de) | 2002-08-15 |
EP1100767B1 (de) | 2002-07-24 |
DE59902136D1 (de) | 2002-08-29 |
EP1100767A1 (de) | 2001-05-23 |
CA2338649A1 (en) | 2000-02-17 |
DK1100767T3 (da) | 2002-11-11 |
PE20000866A1 (es) | 2000-09-05 |
JP2002522411A (ja) | 2002-07-23 |
PT1100767E (pt) | 2002-11-29 |
US6133479A (en) | 2000-10-17 |
DE19834713A1 (de) | 2000-02-03 |
ES2177308T3 (es) | 2002-12-01 |
CA2338649C (en) | 2008-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2161085T3 (es) | Formulaciones que contienen oxaliplatino. | |
AR034897A1 (es) | Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos | |
ES2076688T3 (es) | Derivados de 2-hidroxi-2-feniletilamina utiles como agonistas de beta-3-adrenoceptores. | |
AR023423A1 (es) | Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos | |
AR001332A1 (es) | Nuevos compuestos antagonistas de la taquicinina, proceso para obtenerlos y composiciones farmaceuticas que los contienen. | |
ES2054860T5 (es) | Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos. | |
UY27740A1 (es) | Nuevos compuestos | |
ES2195785B1 (es) | Nuevos derivados de piridazin-3(2h)-ona. | |
AR024345A1 (es) | Derivados de purina | |
AR023275A1 (es) | Derivados de la purina | |
AR025962A1 (es) | Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que los contienen | |
ES2187814T3 (es) | Derivados de pirazolopiridinopiridazinonas y procedimiento para su preparacion. | |
AR009413A1 (es) | Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende | |
AR004498A1 (es) | Compuestos de aminofosfonato y composiciones farmaceuticas que los contienen, el uso de los mismos, y un procedimiento para su preparacion | |
CY1105028T1 (el) | Υποκατεστημενες c-ιμιδαζο-[1,2-α]πυριδιν-3-υλο-μεθυλαμινες | |
AR009741A1 (es) | Nuevos derivados de la benzamidina, procedimiento para prepararlos, preparados farmaceuticos que los contienen y su empleo como medicamentos. | |
AR018162A1 (es) | Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica | |
MX9306311A (es) | Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
ES2043665T3 (es) | 6,11-dihidro-11-(4-piperidiliden)-5h-benzo-(5,6)-ciclohepta-(1,2-b)-piridinas y composiciones y metodos de uso. | |
MX9300399A (es) | Derivados heterotriciclicos. | |
CY1105019T1 (el) | Υποκατεστημενες c-ιμιδαζο-[1,2-α]πυριδιν-3-υλο-μεθυλαμινες | |
ECSP034531A (es) | Derivados sustituidos de c-ciclohexilmetilamina | |
UY25357A1 (es) | Nuevos pentasacáridos, procedimiento para su preparación y composiciones farmacéuticas que los contienen. | |
AR008244A1 (es) | Compuestos heterociclicos, procedimiento para prepararlos, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la fabricacion de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos | |
AR019975A1 (es) | Derivados de feniletilamina, procedimiento para su preparacion, preparado farmaceutico que los contiene y su utilizacion |